Good morning :)
Quick Heal Technologies Ltd

Quick Heal Technologies Ltd

QUICKHEAL Share Price

NSE
180.010.89% (-1.61)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹976 cr, stock is ranked 1,530

Stock is 4.05x as volatile as Nifty

QUICKHEAL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹976 cr, stock is ranked 1,530

Stock is 4.05x as volatile as Nifty

QUICKHEAL Performance & Key Metrics

QUICKHEAL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-89.342.21
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
21.625.833.21%

QUICKHEAL Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

QUICKHEAL Company Profile

Quick Heal Technologies Limited provides information technology security solutions.

QUICKHEAL Similar Stocks (Peers)

Compare with peers Compare with peers 

QUICKHEAL Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
16.17
16.17
1Y Return
34.77%
34.77%
Buy Reco %
69.05
69.05
PE Ratio
16.47
16.47
1Y Return
22.96%
22.96%
Buy Reco %
66.67
66.67
PE Ratio
18.77
18.77
1Y Return
29.26%
29.26%
Buy Reco %
37.50
37.50
PE Ratio
15.77
15.77
1Y Return
19.99%
19.99%
Buy Reco %
28.13
28.13
PE Ratio
30.22
30.22
1Y Return
5.07%
5.07%
Buy Reco %
70.27
70.27
Compare with Peers

QUICKHEAL Sentiment Analysis

QUICKHEAL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

QUICKHEAL Stock Summary · May 2026

Management framed the quarter as a strategic inflection point: amid the company’s weakest quarterly profitability and FY26 revenue declining to Rs. 261 crore, leadership is accelerating a deliberate pivot from a consumer antivirus vendor to an integrated enterprise and government cybersecurity provider, targeting enterprise revenues to rise to roughly 80–90% of the top line within 2–3 years. The tone was resolute about sustained investment—R&D and sales & marketing remain prioritized while the product set has been expanded with EDR, XDR, data‑privacy, digital risk protection and ransomware‑recovery services and AI/ML embedded across detection, classification and response; operational threat research and growing cloud deployments were positioned as competitive supports. Management acknowledged clear tension: enterprise and regulatory contract momentum is offsetting consumer weakness and channel headwinds, and tighter credit controls have pressured near‑term top line and receivables. They emphasized a debt‑free balance sheet and intent to continue funding the transformation without drastic cost cuts, expecting enterprise contract traction to drive recovery toward their stated multi‑year targets.

QUICKHEAL Stock Growth Drivers
QUICKHEAL Stock Growth Drivers
7
  • Strategic Repositioning to a Full‑Spectrum Cybersecurity Provider

    The company has executed a deliberate transformation from a B2C antivirus vendor into a broad

  • Enterprise Revenue Momentum and Structural Mix Shift

    The enterprise vertical has scaled significantly—from roughly 20% of revenue five years ago to over

QUICKHEAL Stock Challenges
QUICKHEAL Stock Challenges
6
  • Severe Deterioration in Financial Performance

    The company has moved from roughly Rs.100 crores of annual profit historically to reporting a

  • Persistent Consumer-Vertical Weakness and Industry Headwinds

    The consumer antivirus business is undergoing secular degrowth and consolidation, producing sustained revenue weakness that

QUICKHEAL Forecast

QUICKHEAL Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

QUICKHEAL

QUICKHEAL

Income

Balance Sheet

Cash Flow

QUICKHEAL Income Statement

QUICKHEAL Income Statement

Loading...

Quarterdec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026
Total Revenue86.0786.8575.3578.6975.5270.7462.9887.9080.4952.48
Operating & Other expensessubtract70.3069.9967.7070.4274.3873.6266.9674.2971.0978.05
Depreciation/Amortizationsubtract3.243.182.793.153.393.632.963.283.594.07
Interest & Other Itemssubtract0.000.130.050.050.060.060.060.050.060.03
Taxes & Other Itemssubtract2.47-0.490.780.92-2.42-3.32-1.492.37-0.86-9.73
EPS1.892.630.750.770.02-0.60-1.001.431.19-3.58

QUICKHEAL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Jul 20PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Apr 17PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF

Investor Presentation

May 10PDF
FY 2018FY 2018

Annual report

PDF

Investor Presentation

May 11PDF
Feb 7PDF
Nov 10PDF
FY 2017FY 2017

Annual report

PDF

Investor Presentation

May 12PDF
Apr 5PDF
Feb 3PDF
Nov 14PDF
 

QUICKHEAL Stock Peers

QUICKHEAL Past Performance & Peer Comparison

QUICKHEAL Past Performance & Peer Comparison

Comparing 3 stocks from 
Information TechnologyIT Services & Consulting

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Quick Heal Technologies Ltd-89.342.21
Tata Consultancy Services Ltd16.177.335.00%
Infosys Ltd16.475.204.01%
HCL Technologies Ltd18.774.484.69%

QUICKHEAL Stock Price Comparison

Compare QUICKHEAL with any stock or ETF
Compare QUICKHEAL with any stock or ETF
QUICKHEAL
Loading...

QUICKHEAL Holdings

QUICKHEAL Shareholdings

QUICKHEAL Promoter Holdings Trend

QUICKHEAL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

QUICKHEAL Institutional Holdings Trend

QUICKHEAL Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.44%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

QUICKHEAL Shareholding Pattern

QUICKHEAL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.50%0.00%1.16%0.73%26.61%

Jun 2025

Sep 2025

Dec 2025

Mar 2026

QUICKHEAL Shareholding History

QUICKHEAL Shareholding History

Dec '24MarJunSepDec '25Mar1.81%2.02%1.16%0.50%0.45%0.73%

Mutual Funds Invested in QUICKHEAL

Mutual Funds Invested in QUICKHEAL

No mutual funds holding trends are available

Top 1 Mutual Funds holding Quick Heal Technologies Ltd


Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.0001%0.00%0.00%1005/1008 (-6)

Compare 3-month MF holding change on Screener

QUICKHEAL Insider Trades & Bulk Stock Deals

QUICKHEAL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing QUICKHEAL stock

smallcases containing QUICKHEAL stock

Looks like this stock is not in any smallcase yet.

QUICKHEAL Events

QUICKHEAL Events

QUICKHEAL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

QUICKHEAL Dividend Trend

No dividend trend available

QUICKHEAL Upcoming Dividends

QUICKHEAL Upcoming Dividends

No upcoming dividends are available

QUICKHEAL Past Dividends

QUICKHEAL Past Dividends

Cash Dividend

Ex DateEx DateAug 30, 2024

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Aug 30, 2024

Cash Dividend

Ex DateEx DateJul 28, 2023

Final
Final | Div/Share: ₹2.50

Dividend/Share

2.50

Ex DateEx Date

Jul 28, 2023

Cash Dividend

Ex DateEx DateAug 18, 2022

Final
Final | Div/Share: ₹4.50

Dividend/Share

4.50

Ex DateEx Date

Aug 18, 2022

Cash Dividend

Ex DateEx DateJul 29, 2021

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Jul 29, 2021

Cash Dividend

Ex DateEx DateMar 2, 2020

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Mar 2, 2020

QUICKHEAL Stock News & Opinions

QUICKHEAL Stock News & Opinions

Spotlight
Spotlight
Quick Heal Tech slides after Q4 net loss widens to Rs 20 crore

Revenue from operations declined 25.19% year on year (YoY) to Rs 48.73 crore in the quarter ended 31 March 2026. The company reported a loss before tax of Rs 29.67 crore in Q4 FY26, compared with a loss of Rs 6.57 crore in the corresponding quarter last year. EBITDA loss widened to Rs 29.3 crore in Q4 FY26 from Rs 8.5 crore in Q4 FY25, while EBITDA margin deteriorated to a loss of 60.2% from 13% in the year-ago period. Dr. Kailash Katkar, Chairman and Managing Director of Quick Heal Technologies, commented, 'This year has been a mixed one for us. While the consumer vertical faced headwinds due to broader market challenges, our enterprise vertical delivered consistent growth and strong momentum. The industry continues to evolve amid rising geopolitical tensions, an increasingly dynamic AI-driven threat landscape, and changing regulatory environments. At the same time, data privacy regulations have unlocked a significant market opportunity for us. As the industry shifts from reactive to predictive and pre-emptive cybersecurity, we remain committed to transforming ourselves into a full-stack, AI-native, and AI-driven cybersecurity company. Our focused efforts on the enterprise vertical are helping us overcome the challenges faced in the consumer vertical. Based on the progress we are seeing, we believe we should be able to navigate these challenges over the next three to four quarters, with the enterprise business contributing a major share of our revenue.' Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies, added, 'The enterprise business continued to deliver healthy growth during the year, supported by strong execution and customer traction. Within the Enterprise vertical, we have seen greater success through government and international teams. The consumer business already facing industry headwinds got further impacted due to rising hardware prices. Hence, we have tightened our control on the credit cycles with the partners, thereby impacting the topline. At the same time, costs remained stable, reflecting continued operational discipline. The strategic order announced last year for implementation of Cyber Literacy program was successfully executed, and we secured another significant order for implementation of Integrated Cyber Security Solutions worth 64 Crs during the year. Deferred revenue continued to witness growth, providing improved visibility and confidence in our future performance.' Quick Heal Technologies is a leading global cybersecurity solutions provider. Incorporated in 1995 with a registered office in Pune, it offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. With its widely recognized brands 'Quick Heal' and 'Seqrite', the company provides AIpowered, patented technologies that protect endpoints, networks, data, mobility, and cloud environments. Committed to R&D and innovation, Quick Heal Technologies continues to simplify security by delivering best-in-class protection against advanced cyber-threats to millions of customers, enterprises, and government organizations worldwide. Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Earnings
Quick Heal Technologies reports consolidated net loss of Rs 19.94 crore in the March 2026 quarter

Net Loss of Quick Heal Technologies reported to Rs 19.94 crore in the quarter ended March 2026 as against net loss of Rs 3.25 crore during the previous quarter ended March 2025. Sales declined 25.19% to Rs 48.73 crore in the quarter ended March 2026 as against Rs 65.14 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 10.93 crore in the year ended March 2026 as against net profit of Rs 5.04 crore during the previous year ended March 2025. Sales declined 6.62% to Rs 261.02 crore in the year ended March 2026 as against Rs 279.53 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales48.7365.14 -25 261.02279.53 -7 OPM %-60.17-13.02 --11.25-2.36 - PBDT-25.60-2.94 -771 -6.7413.96 PL PBT-29.67-6.57 -352 -20.641.00 PL NP-19.94-3.25 -514 -10.935.04 PL Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies to convene board meeting

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 21 May 2026.

3 weeks agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies alltos 18,015 equity shares under ESOP

Quick Heal Technologies has allotted 18,015 equity shares under ESOP on 27 February 2026. Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies allots 153 equity shares under ESOP

Quick Heal Technologies has allotted 153 equity shares under ESOP on 30 January 2026. With this allotment, the paid up equity share capital has increased to Rs 54,21,50,750/- divided into 5,42,15,075 Nos. of Equity Share of Rs 10/- each. Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies announces board meeting date

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies allots 15,352 equity shares under ESOP

Quick Heal Technologies has allotted 15,352 equity shares under ESOP on 24 December 2025. Powered by Capital Market - Live

5 months agoCapital Market - Live
Spotlight
Spotlight
Quick Heal Tech gains on securing Rs 64-cr cybersecurity contract from NFSU-RIC

The company said the engagement is aligned with its ongoing cybersecurity business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. Powered by Capital Market - Live

6 months agoCapital Market - Live
Spotlight
Spotlight
Quick Heal Tech secures Rs 64-cr cyber security contract from NFSU-RIC

The company said the engagement is aligned with its ongoing cyber security business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on a 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. The counter rose 1.82% to settle at Rs 307.50 on the BSE. Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Corporate
Quick Heal Technologies announces resignation of senior management personnel

Quick Heal Technologies announced that Ajit Zanjad, Vice President Head of Delivery of the Company, has tendered his resignation from the services of the Company for professional growth, with effect from 28 November 2025. Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Quick Heal Technologies Ltd (QUICKHEAL) today?

    The share price of QUICKHEAL as on 5th June 2026 is ₹180.01. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Quick Heal Technologies Ltd (QUICKHEAL) share?

    The past returns of Quick Heal Technologies Ltd (QUICKHEAL) share are
    • Past 1 week: -5.99%
    • Past 1 month: 6.54%
    • Past 3 months: 17.34%
    • Past 6 months: -37.88%
    • Past 1 year: -48.37%
    • Past 3 years: 23.30%
    • Past 5 years: -21.05%

  3. What are the peers or stocks similar to Quick Heal Technologies Ltd (QUICKHEAL)?

    The peers or stocks similar to Quick Heal Technologies Ltd (QUICKHEAL) include:

  4. What is the market cap of Quick Heal Technologies Ltd (QUICKHEAL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Quick Heal Technologies Ltd (QUICKHEAL) is ₹976.52 Cr as of 5th June 2026.

  5. What is the 52 week high and low of Quick Heal Technologies Ltd (QUICKHEAL) share?

    The 52-week high of Quick Heal Technologies Ltd (QUICKHEAL) is ₹416.70 and the 52-week low is ₹125.

  6. What is the PE and PB ratio of Quick Heal Technologies Ltd (QUICKHEAL) stock?

    The P/E (price-to-earnings) ratio of Quick Heal Technologies Ltd (QUICKHEAL) is -89.34. The P/B (price-to-book) ratio is 2.21.

  7. Which sector does Quick Heal Technologies Ltd (QUICKHEAL) belong to?

    Quick Heal Technologies Ltd (QUICKHEAL) belongs to the Information Technology sector & IT Services & Consulting sub-sector.

  8. How to buy Quick Heal Technologies Ltd (QUICKHEAL) shares?

    You can directly buy Quick Heal Technologies Ltd (QUICKHEAL) shares on Tickertape. Simply sign up, connect your demat account and place your order.